FDA approves J&J's prostate cancer drug Erleada in new use, ...

The FDA has approved Johnson & Johnson’s prostate cancer drug Erleada (apalutamide) for patients whose prostate cancer has spread.

FDA starts quick review of Astellas/Seattle Genetics’ bladde...

IQVIA launches UK cancer database amid survival rate concern

As figures show the UK continues to lag behind other developed countries in cancer survival, a new project aims to create a national database with ambitious goals to challenge the variation

Tocagen plummets on phase 3 data for glioma therapy

As 'big three' oncology meds lose sales, Roche looks to file...

A subcutaneous formulation of Roche’s Perjeta and Herceptin breast cancer drugs works as well as an original intravenous (IV) version, a study has shown.

Henlius Biotech shrugs off Hong Kong disruption with $477M I...